Rheumatoid arthritis (refractory) - abatacept
Abatacept for the treatment of rheumatoid arthritis
Summary
Abatacept is not recommended for people with moderate to severe active rheumatoid arthritis who have already tried drugs known as disease-modifying anti-rheumatic drugs (including a 'TNF inhibitor'drug), which didn't work or weren't suitable.Healthcare professionals should not stop prescribing abata ...
Guidance documents
Implementing this guidance
We will consult on our review plans for this guidance in July 2010
About this guidance
Technology appraisals TA141
Issued: April 2008
